{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T21:30:18Z","timestamp":1792099818027,"version":"4.4.0"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100014786","name":"Northern Border University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014786","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.cca.2026.120938","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T07:53:10Z","timestamp":1772524390000},"page":"120938","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Glycoprotein biomarkers for bladder cancer detection"],"prefix":"10.1016","volume":"586","author":[{"given":"Abida","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadiyah Jadid","family":"Alanazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saif","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah R.","family":"Alzahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zia Ur","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahia Hassan","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Intisar Kamil","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Irfan","family":"Siddique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.cca.2026.120938_bb0005","doi-asserted-by":"crossref","first-page":"617","DOI":"10.4103\/jcrt.jcrt_134_21","article-title":"Unusual histomorphological spectrum of urinary bladder cancers and their treatment modalities revisited: our experience with series of five cases","volume":"19","author":"Mohanty","year":"2023","journal-title":"J. Cancer Res. Ther."},{"issue":"1","key":"10.1016\/j.cca.2026.120938_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/BLC-220106","article-title":"Recent advances in the classification of bladder cancer - updates from the 5th edition of the World Health Organization classification of the urinary and male genital tumors","volume":"9","author":"Guo","year":"2023","journal-title":"Bladder cancer (Amsterdam, Netherlands)"},{"key":"10.1016\/j.cca.2026.120938_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2025.118209","article-title":"Revealing the role of bisphenol a on prostate cancer progression and identifying potential targets: a comprehensive analysis from population cohort to molecular mechanism","volume":"296","author":"Zhou","year":"2025","journal-title":"Ecotoxicol. Environ. Saf."},{"issue":"6","key":"10.1016\/j.cca.2026.120938_bb0020","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/ncpuro0510","article-title":"Mechanisms of disease: the epidemiology of bladder cancer","volume":"3","author":"Pelucchi","year":"2006","journal-title":"Nat. Clin. Pract. Urol."},{"issue":"4","key":"10.1016\/j.cca.2026.120938_bb0025","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1080\/10590501.2013.844755","article-title":"Understanding the gender disparity in bladder cancer risk: the impact of sex hormones and liver on bladder susceptibility to carcinogens","volume":"31","author":"Zhang","year":"2013","journal-title":"J. Environ. Sci. Health, Part C"},{"issue":"7","key":"10.1016\/j.cca.2026.120938_bb0030","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1021\/pr0700807","article-title":"Bladder cancer associated glycoprotein signatures revealed by urinary proteomic profiling","volume":"6","author":"Kreunin","year":"2007","journal-title":"J. Proteome Res."},{"issue":"10","key":"10.1016\/j.cca.2026.120938_bb0035","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1158\/1078-0432.CCR-10-3121","article-title":"Urinary glycoprotein biomarker discovery for bladder cancer detection using LC\/MS-MS and label-free quantification","volume":"17","author":"Yang","year":"2011","journal-title":"Clinical cancer research\u202f: an official journal of the American Association for Cancer Research"},{"issue":"10","key":"10.1016\/j.cca.2026.120938_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26104891","article-title":"Glycomics and Glycoproteomics reveal distinct Oligomannose carriers across bladder Cancer stages","volume":"26","author":"Relvas-Santos","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.cca.2026.120938_bb0045","article-title":"Comparative N-Glycoproteomics reveals subtype-specific N-glycosylation signatures and immune associations in cholangiocarcinoma","volume":"24","author":"Xia","year":"2025","journal-title":"Molecular & cellular proteomics\u202f: MCP"},{"key":"10.1016\/j.cca.2026.120938_bb0050","article-title":"The complexity and dynamics of the tissue Glycoproteome associated with prostate Cancer progression","volume":"20","author":"Kawahara","year":"2021","journal-title":"Molecular & cellular proteomics\u202f: MCP"},{"issue":"1","key":"10.1016\/j.cca.2026.120938_bb0055","article-title":"Urinary extracellular vesicle N-glycomics identifies diagnostic glycosignatures for bladder cancer","volume":"16","author":"Li","year":"2025","journal-title":"Nat. Commun."},{"issue":"11","key":"10.1016\/j.cca.2026.120938_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/metabo11110756","article-title":"Urinary metabolic markers of bladder Cancer: a reflection of the tumor or the response of the body?","volume":"11","author":"Petrella","year":"2021","journal-title":"Metabolites"},{"issue":"1","key":"10.1016\/j.cca.2026.120938_bb0065","article-title":"Identification of multicohort-based predictive signature for NMIBC recurrence reveals SDCBP as a novel oncogene in bladder cancer","volume":"57","author":"Zhang","year":"2025","journal-title":"Ann. Med."},{"issue":"8","key":"10.1016\/j.cca.2026.120938_bb0070","doi-asserted-by":"crossref","DOI":"10.3390\/molecules28083436","article-title":"Altered glycosylation in progression and management of bladder cancer","volume":"28","author":"Wilczak","year":"2023","journal-title":"Molecules (Basel, Switzerland)"},{"issue":"3","key":"10.1016\/j.cca.2026.120938_bb0075","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.molonc.2014.02.008","article-title":"Sialyl Tn-expressing bladder cancer cells induce a tolerogenic phenotype in innate and adaptive immune cells","volume":"8","author":"Carrascal","year":"2014","journal-title":"Mol. Oncol."},{"issue":"10","key":"10.1016\/j.cca.2026.120938_bb0080","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.7150\/ijbs.109973","article-title":"Novel glycoprotein SBSPON suppressed bladder cancer through the AKT signal pathway by inhibiting HSPA5 membrane translocation","volume":"21","author":"Ni","year":"2025","journal-title":"Int. J. Biol. Sci."},{"issue":"39","key":"10.1016\/j.cca.2026.120938_bb0085","doi-asserted-by":"crossref","first-page":"63138","DOI":"10.18632\/oncotarget.11257","article-title":"Hypoxia enhances the malignant nature of bladder cancer cells and concomitantly antagonizes protein O-glycosylation extension","volume":"7","author":"Peixoto","year":"2016","journal-title":"Oncotarget"},{"issue":"34","key":"10.1016\/j.cca.2026.120938_bb0090","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.18632\/oncotarget.27696","article-title":"Urinary glycoproteomic profiling of non-muscle invasive and muscle invasive bladder carcinoma patients reveals distinct N-glycosylation pattern of CD44, MGAM, and GINM1","volume":"11","author":"Sathe","year":"2020","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.cca.2026.120938_bb0095","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1093\/glycob\/cwab083","article-title":"Major differences in glycosylation and fucosyltransferase expression in low-grade versus high-grade bladder cancer cell lines","volume":"31","author":"Ezeabikwa","year":"2021","journal-title":"Glycobiology"},{"issue":"8","key":"10.1016\/j.cca.2026.120938_bb0100","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/1878-0261.12035","article-title":"Targeted O-glycoproteomics explored increased sialylation and identified MUC16 as a poor prognosis biomarker in advanced-stage bladder tumours","volume":"11","author":"Cotton","year":"2017","journal-title":"Mol. Oncol."},{"issue":"7","key":"10.1016\/j.cca.2026.120938_bb0105","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.7150\/thno.67409","article-title":"Glycoproteogenomics characterizes the CD44 splicing code associated with bladder cancer invasion","volume":"12","author":"Gaiteiro","year":"2022","journal-title":"Theranostics"},{"issue":"9","key":"10.1016\/j.cca.2026.120938_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24098213","article-title":"Bladder Cancer cells interaction with lectin-coated surfaces under static and flow conditions","volume":"24","author":"Szydlak","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.cca.2026.120938_bb0115","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18122632","article-title":"Aberrant N-glycosylation profile of serum immunoglobulins is a diagnostic biomarker of urothelial carcinomas","volume":"18","author":"Tanaka","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"33","key":"10.1016\/j.cca.2026.120938_bb0120","doi-asserted-by":"crossref","first-page":"54506","DOI":"10.18632\/oncotarget.17138","article-title":"Expression of sialyl-Tn sugar antigen in bladder cancer cells affects response to Bacillus Calmette Gu\u00e9rin (BCG) and to oxidative damage","volume":"8","author":"Severino","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.cca.2026.120938_bb0125","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12964-019-0500-x","article-title":"Sialidase NEU1 suppresses progression of human bladder cancer cells by inhibiting fibronectin-integrin \u03b15\u03b21 interaction and Akt signaling pathway","volume":"18","author":"Zhou","year":"2020","journal-title":"Cell communication and signaling : CCS"},{"issue":"22","key":"10.1016\/j.cca.2026.120938_bb0130","doi-asserted-by":"crossref","first-page":"10078","DOI":"10.7150\/thno.48711","article-title":"Identification of glycogene-type and validation of ST3GAL6 as a biomarker predicts clinical outcome and cancer cell invasion in urinary bladder cancer","volume":"10","author":"Dalangood","year":"2020","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.cca.2026.120938_bb0135","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1186\/s12885-024-12712-w","article-title":"Results from a real-world study: a novel glycosyltransferase risk score for prognosis, tumor microenvironment phenotypes and immunotherapy in bladder cancer","volume":"24","author":"Liu","year":"2024","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.cca.2026.120938_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines13030682","article-title":"Low GCNT2\/I-branching glycan expression is associated with bladder Cancer aggressiveness","volume":"13","author":"Tobisawa","year":"2025","journal-title":"Biomedicines"},{"issue":"2","key":"10.1016\/j.cca.2026.120938_bb0145","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1021\/pr5006026","article-title":"Quantitative glycome analysis of N-glycan patterns in bladder cancer vs normal bladder cells using an integrated strategy","volume":"14","author":"Yang","year":"2015","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.cca.2026.120938_bb0150","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.2147\/JIR.S499403","article-title":"The benefits and safety of monoclonal antibodies: implications for Cancer immunotherapy","volume":"18","author":"Zhang","year":"2025","journal-title":"J. Inflamm. Res."},{"key":"10.1016\/j.cca.2026.120938_bb0155","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-9-357","article-title":"ST3Gal.I sialyltransferase relevance in bladder cancer tissues and cell lines","volume":"9","author":"Videira","year":"2009","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.cca.2026.120938_bb0160","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.molonc.2013.03.001","article-title":"Overexpression of tumour-associated carbohydrate antigen sialyl-Tn in advanced bladder tumours","volume":"7","author":"Ferreira","year":"2013","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.cca.2026.120938_bb0165","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.2147\/JIR.S296597","article-title":"FUT7 promotes the epithelial-mesenchymal transition and immune infiltration in bladder urothelial carcinoma","volume":"14","author":"Liu","year":"2021","journal-title":"J. Inflamm. Res."},{"issue":"6","key":"10.1016\/j.cca.2026.120938_bb0170","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.3892\/or.2020.7795","article-title":"Analysis of the correlation between alterations in N-glycans and invasiveness in liver cancer cell lines","volume":"44","author":"Takahashi","year":"2020","journal-title":"Oncol. Rep."},{"issue":"4","key":"10.1016\/j.cca.2026.120938_bb0175","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/ijc.10246","article-title":"Increased expression of multidrug resistance-associated proteins in bladder cancer during clinical course and drug resistance to doxorubicin","volume":"98","author":"Tada","year":"2002","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.cca.2026.120938_bb0180","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1136\/jcp.2007.049460","article-title":"EpCAM is predominantly expressed in high grade and advanced stage urothelial carcinoma of the bladder","volume":"61","author":"Brunner","year":"2008","journal-title":"J. Clin. Pathol."},{"issue":"2","key":"10.1016\/j.cca.2026.120938_bb0185","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1158\/1535-7163.MCT-17-1079","article-title":"Glycoprotein-130 expression is associated with aggressive bladder Cancer and is a potential therapeutic target","volume":"18","author":"Martin","year":"2019","journal-title":"Mol. Cancer Ther."},{"issue":"22","key":"10.1016\/j.cca.2026.120938_bb0190","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232214368","article-title":"Lectin-based study reveals the presence of disease-relevant Glycoepitopes in bladder Cancer cells and Ectosomes","volume":"23","author":"Surman","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cca.2026.120938_bb0195","doi-asserted-by":"crossref","DOI":"10.1007\/s11255-025-04708-7","article-title":"High-density lectin microarray uncovers stage-specific plasma glycoprofiling signatures for non-muscle-invasive and muscle-invasive bladder cancer","author":"Xiang","year":"2025","journal-title":"Int. Urol. Nephrol."},{"issue":"3","key":"10.1016\/j.cca.2026.120938_bb0200","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1177\/1724600820935473","article-title":"Novel serum peptide model revealed by MALDI-TOF-MS and its diagnostic value in early bladder cancer","volume":"35","author":"Ding","year":"2020","journal-title":"Int. J. Biol. Markers"},{"issue":"1","key":"10.1016\/j.cca.2026.120938_bb0205","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/s41598-023-50957-w","article-title":"An N-glycome tissue atlas of 15 human normal and cancer tissue types determined by MALDI-imaging mass spectrometry","volume":"14","author":"Wallace","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.cca.2026.120938_bb0210","doi-asserted-by":"crossref","first-page":"1160965","DOI":"10.3389\/fonc.2023.1160965","article-title":"LC-MS based urine untargeted metabolomic analyses to identify and subdivide urothelial cancer","volume":"13","author":"Yang","year":"2023","journal-title":"Front. Oncol."},{"issue":"10","key":"10.1016\/j.cca.2026.120938_bb0215","doi-asserted-by":"crossref","DOI":"10.1093\/nsr\/nwaf357","article-title":"Ultrasensitive optoelectronic biosensor arrays based on twisted bilayer graphene superlattice","volume":"12","author":"Du","year":"2025","journal-title":"Natl. Sci. Rev."},{"issue":"1","key":"10.1016\/j.cca.2026.120938_bb0220","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/s12967-016-1043-1","article-title":"A multiplex urinary immunoassay for bladder cancer detection: analysis of a Japanese cohort","volume":"14","author":"Goodison","year":"2016","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.cca.2026.120938_bb0225","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1186\/s12967-025-06749-z","article-title":"Performance of the Oncuria-detect bladder cancer test for evaluating patients presenting with haematuria: results from a real-world clinical setting","volume":"23","author":"Pagano","year":"2025","journal-title":"J. Transl. Med."},{"issue":"9","key":"10.1016\/j.cca.2026.120938_bb0230","doi-asserted-by":"crossref","first-page":"811","DOI":"10.7150\/ijms.19929","article-title":"Urinary UBC rapid and NMP22 test for bladder Cancer surveillance in comparison to urinary cytology: results from a prospective single-center study","volume":"14","author":"Pichler","year":"2017","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.cca.2026.120938_bb0235","doi-asserted-by":"crossref","first-page":"1309842","DOI":"10.3389\/fonc.2024.1309842","article-title":"Exploration of potential biomarkers for early bladder cancer based on urine proteomics","volume":"14","author":"Zhou","year":"2024","journal-title":"Front. Oncol."},{"issue":"9","key":"10.1016\/j.cca.2026.120938_bb0240","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1158\/1055-9965.EPI-14-0029","article-title":"External validation of a multiplex urinary protein panel for the detection of bladder cancer in a multicenter cohort","volume":"23","author":"Chen","year":"2014","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"issue":"10","key":"10.1016\/j.cca.2026.120938_bb0245","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1016\/j.ajpath.2025.06.005","article-title":"The substructure of the endothelial Glycocalyx in rat aorta and its interaction with the low-density lipoproteins","volume":"195","author":"Kang","year":"2025","journal-title":"Am. J. Pathol."},{"issue":"1","key":"10.1016\/j.cca.2026.120938_bb0250","doi-asserted-by":"crossref","first-page":"10999","DOI":"10.1038\/s41598-020-67929-z","article-title":"Circulating proteomic signature for detection of biomarkers in bladder cancer patients","volume":"10","author":"Nedjadi","year":"2020","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.cca.2026.120938_bb0255","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1038\/sj.ki.5000273","article-title":"Collection, storage, preservation, and normalization of human urinary exosomes for biomarker discovery","volume":"69","author":"Zhou","year":"2006","journal-title":"Kidney Int."},{"issue":"7","key":"10.1016\/j.cca.2026.120938_bb0260","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0201208","article-title":"Behavior of blood plasma glycan features in bladder cancer","volume":"13","author":"Ferdosi","year":"2018","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.cca.2026.120938_bb0265","article-title":"Effects of different voided urine sample storage time, temperature, and preservatives on analysis with multiplex bead-based Oncuria bladder cancer immunoassay","volume":"15","author":"Tanaka","year":"2025","journal-title":"Diagnostics (Basel, Switzerland)"},{"issue":"1","key":"10.1016\/j.cca.2026.120938_bb0270","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12916-023-02813-x","article-title":"Comprehensive proteomics and platform validation of urinary biomarkers for bladder cancer diagnosis and staging","volume":"21","author":"Vanarsa","year":"2023","journal-title":"BMC Med."},{"key":"10.1016\/j.cca.2026.120938_bb0275","doi-asserted-by":"crossref","first-page":"1280428","DOI":"10.3389\/fphar.2023.1280428","article-title":"A glycosylation risk score comprehensively assists the treatment of bladder neoplasm in the real-world cohort, including the tumor microenvironment, molecular and clinical prognosis","volume":"14","author":"Liu","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.cca.2026.120938_bb0280","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1080\/08923973.2024.2402338","article-title":"Clinical features, treatment, and outcome of nivolumab-induced cholangitis","volume":"46","author":"He","year":"2024","journal-title":"Immunopharmacol. Immunotoxicol."},{"issue":"7","key":"10.1016\/j.cca.2026.120938_bb0285","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.21037\/tcr-24-2013","article-title":"Identification and validation of a novel signature based on M2 macrophage co-expressed genes in bladder cancer","volume":"14","author":"Xu","year":"2025","journal-title":"Transl. Cancer Res."},{"issue":"12","key":"10.1016\/j.cca.2026.120938_bb0290","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1111\/jvh.13886","article-title":"CHB patients with rtA181T-mutated HBV infection are associated with higher risk hepatocellular carcinoma due to increases in mutation rates of tumour suppressor genes","volume":"30","author":"Ning","year":"2023","journal-title":"J. Viral Hepat."},{"issue":"8","key":"10.1016\/j.cca.2026.120938_bb0295","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1038\/bjc.2013.571","article-title":"Response of high-risk of recurrence\/progression bladder tumours expressing sialyl-Tn and sialyl-6-T to BCG immunotherapy","volume":"109","author":"Lima","year":"2013","journal-title":"Br. J. Cancer"},{"issue":"7","key":"10.1016\/j.cca.2026.120938_bb0300","first-page":"1340","article-title":"Urinary protein biomarker panel for the detection of recurrent bladder cancer, Cancer epidemiology, biomarkers & prevention\u202f: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive","volume":"23","author":"Rosser","year":"2014","journal-title":"Oncology"},{"issue":"8","key":"10.1016\/j.cca.2026.120938_bb0305","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/s42256-024-00868-w","article-title":"A transformer-based weakly supervised computational pathology method for clinical-grade diagnosis and molecular marker discovery of gliomas","volume":"6","author":"Jiang","year":"2024","journal-title":"Nature Machine Intelligence"},{"issue":"11","key":"10.1016\/j.cca.2026.120938_bb0310","doi-asserted-by":"crossref","first-page":"10844","DOI":"10.18632\/aging.103297","article-title":"Aberrantly glycosylated integrin \u03b13\u03b21 is a unique urinary biomarker for the diagnosis of bladder cancer","volume":"12","author":"Jin","year":"2020","journal-title":"Aging"},{"issue":"11","key":"10.1016\/j.cca.2026.120938_bb0315","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1038\/sj.bjc.6605083","article-title":"Sialyl-Tn vaccine induces antibody-mediated tumour protection in a relevant murine model","volume":"100","author":"Julien","year":"2009","journal-title":"Br. J. Cancer"},{"issue":"7","key":"10.1016\/j.cca.2026.120938_bb0320","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1007\/s00018-014-1799-5","article-title":"Cancer intelligence acquired (CIA): tumor glycosylation and sialylation codes dismantling antitumor defense","volume":"72","author":"Boligan","year":"2015","journal-title":"Cellular and molecular life sciences\u202f: CMLS"},{"issue":"1","key":"10.1016\/j.cca.2026.120938_bb0325","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/19336918.2018.1491234","article-title":"Role of glycosylation in hypoxia-driven cell migration and invasion","volume":"13","author":"Arriagada","year":"2019","journal-title":"Cell Adhes. Migr."},{"issue":"5","key":"10.1016\/j.cca.2026.120938_bb0330","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2174\/1568009618666180430123939","article-title":"Blocking IL-6\/GP130 signaling inhibits cell viability\/proliferation, glycolysis, and Colony forming activity in human pancreatic Cancer cells","volume":"19","author":"Chen","year":"2019","journal-title":"Curr. Cancer Drug Targets"},{"issue":"6","key":"10.1016\/j.cca.2026.120938_bb0335","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.molmed.2014.02.007","article-title":"MUC1: a multifaceted oncoprotein with a key role in cancer progression","volume":"20","author":"Nath","year":"2014","journal-title":"Trends Mol. Med."},{"issue":"4","key":"10.1016\/j.cca.2026.120938_bb0340","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1002\/cam4.3727","article-title":"N-glycan signature of serum immunoglobulins as a diagnostic biomarker of urothelial carcinomas","volume":"10","author":"Kodama","year":"2021","journal-title":"Cancer Med."},{"issue":"2","key":"10.1016\/j.cca.2026.120938_bb0345","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00418-016-1520-x","article-title":"Sialylation of N-glycans: mechanism, cellular compartmentalization and function","volume":"147","author":"Bhide","year":"2017","journal-title":"Histochem. Cell Biol."},{"issue":"6","key":"10.1016\/j.cca.2026.120938_bb0350","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1631\/jzus.B2300917","article-title":"Sialyltransferase ST3GAL6 silencing reduces \u03b12,3-sialylated glycans to regulate autophagy by decreasing HSPB8-BAG3 in the brain with hepatic encephalopathy","volume":"25","author":"Li","year":"2024","journal-title":"J. Zhejiang Univ. Sci. B"},{"issue":"19","key":"10.1016\/j.cca.2026.120938_bb0355","doi-asserted-by":"crossref","first-page":"7300","DOI":"10.1074\/jbc.RA117.000775","article-title":"Distinct human \u03b1(1,3)-fucosyltransferases drive Lewis-X\/sialyl Lewis-X assembly in human cells","volume":"293","author":"Mondal","year":"2018","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.cca.2026.120938_bb0360","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/bjd.19891","article-title":"Melanoma-associated glycosyltransferase GCNT2 as an emerging biomarker and therapeutic target","volume":"185","author":"Perez","year":"2021","journal-title":"Br. J. Dermatol."},{"issue":"15","key":"10.1016\/j.cca.2026.120938_bb0365","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1038\/emboj.2011.215","article-title":"A novel strategy for evasion of NK cell immunity by tumours expressing core2 O-glycans","volume":"30","author":"Tsuboi","year":"2011","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.cca.2026.120938_bb0370","doi-asserted-by":"crossref","first-page":"10109","DOI":"10.1038\/s41598-025-94496-y","article-title":"Combination of urinary free-glycan markers for the diagnosis of various malignant tumors","volume":"15","author":"Tanaka-Okamoto","year":"2025","journal-title":"Sci. Rep."},{"issue":"6","key":"10.1016\/j.cca.2026.120938_bb0375","doi-asserted-by":"crossref","first-page":"7101","DOI":"10.18632\/oncotarget.23872","article-title":"Meta-analysis of a 10-plex urine-based biomarker assay for the detection of bladder cancer","volume":"9","author":"Masuda","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.cca.2026.120938_bb0380","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12967-016-0783-2","article-title":"A multiplex immunoassay for the non-invasive detection of bladder cancer","volume":"14","author":"Shimizu","year":"2016","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.cca.2026.120938_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.ab.2021.114283","article-title":"Detection of bladder cancer with aberrantly fucosylated ITGA3","volume":"628","author":"Islam","year":"2021","journal-title":"Anal. Biochem."}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126001208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898126001208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T08:27:13Z","timestamp":1784017633000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898126001208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":77,"alternative-id":["S0009898126001208"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2026.120938","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glycoprotein biomarkers for bladder cancer detection","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2026.120938","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"120938"}}